Penny Hill, Prompt Response Network Lead and Emerging Drugs Research Fellow at NCCRED presented at the NDARC Webinar Sereis on Thursday 17 June 2021.
This presentation covered the development of the national Prompt Response Network for emerging drugs.
The Prompt Response Network is a collaborated effort to empower consumers and communities and aims to ultimately reduce the risk of events related to emerging substances. This seminar will explain the processes involved in building the network and facilitating collaboration across jurisdictions while supporting, being sensitive to, and avoiding duplication of, existing efforts to communicate information regarding events of concern and emerging substances.
About the speakers
Penny Hill is the Prompt Response Network Lead and Emerging Drugs Research Fellow at NCCRED. She has a background in the community health and harm reduction sectors, working and volunteering in needle syringe programs, primary health care facilities and drug checking services in Australia and internationally. She is currently completing her PhD with the Burnet Institute, investigating opioid overdose among a cohort of people who inject drugs, and holds a Master of Science (Public Health), Graduate Diploma in Development Studies (International Development), and Bachelor of Health Sciences. She is a current board member of Harm Reduction Victoria, Harm Reduction Australia, the Vienna NGO Committee on Drugs, the International Drug Policy Consortium’s Members Advisory Council, and is the co-founder of Students for Sensible Drug Policy Australia.
Paul Dessauer has worked for Peer Based Harm Reduction WA (a not-for-profit NGO that provides health services and harm reduction programs for people who use illicit drugs) for more than 21 years. Paul coordinates the outreach team, delivering needle and syringe exchange and other harm reduction services in the community, and he provides consultancy and training to other agencies.
Dr Jessamine Soderstrom is the Emergency Physican and Clinical Toxicologist at Royal Perth Hospital and the National Posions Network, and Research Lead for the Emerging Drug Network of Australia (EDNA) project.
Please note: readers and audience are encouraged to go to the presenter’s published paper for the most fulsome account of the research and its findings.